Westlin Corporation (WSTN) Peer Comparison
$10.18
$0.02
(0.20%)
As on 03-Sep-2026 10:56EDT
Market cap
$82 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
82 | 5,031 | 3,544 | 20 | 1 |
Revenue ($ Mln) |
-- | 1,206 | 573 | 6 | 3 |
Net Profit ($ Mln) |
0.47 | 134.79 | 147.29 | 0.07 | -16.79 |
Net Margin (%) |
-- | 11.18 | 25.72 | 1.20 | -671.01 |
RoE (%) |
1.91 | 3.43 | 25.36 | -- | -86.93 |
Price to Earnings |
-- | 37.49 | 25.73 | -- | -- |
Price-To-Book |
-- | 1.22 | 5.88 | 1,802.81 | 0.12 |
Income Statement ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
-- | 1,099.28 | 489.48 | 2.05 | 0.38 |
|
Cost of Revenue
|
-- | 348.16 | 108.64 | 1.39 | 0.35 |
|
Gross Profit
|
-- | 751.12 | 380.84 | 0.66 | 0.03 |
|
Operating Expenses
|
-- | 501.81 | 362.02 | 0.93 | 7.90 |
|
Operating Profit (EBIT)
|
-- | 249.31 | 18.83 | -0.27 | -7.90 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-0.01 | 171.76 | 32.66 | -0.28 | -7.99 |
|
Provision for Tax
|
-- | 59.67 | -118.17 | -- | -- |
|
Profit after Tax (Net Income)
|
-0.01 | 112.09 | 150.83 | -0.28 | -8.76 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
0.02 | 3,878.83 | 548.18 | -0.17 | 16.80 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
0.00 | 1,688.21 | 314.72 | 0.37 | 81.86 |
|
Current Liabilities
|
0.18 | 218.06 | 96.79 | 0.51 | 4.01 |
|
Total Liabilities
|
0.20 | 5,785.10 | 959.69 | 0.71 | 31.61 |
Assets ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.20 | 5,476.69 | 353.58 | 0.26 | 117.38 |
|
Current Assets
|
0.00 | 308.41 | 606.10 | 0.45 | 2.30 |
|
Total Assets
|
-- | 5,785.10 | 959.69 | 0.71 | 31.61 |
|
Total Debt*
|
-- | 1,490.93 | 310.75 | 0.35 | 0.50 |
|
Net Current Assets
|
-- | 90.35 | 509.31 | -0.14 | 12.36 |
Cashflow ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-- | 309.67 | 88.63 | -0.21 | -0.98 |
|
Cash Flow from Investing Activities
|
-- | -680.90 | -35.33 | -- | -- |
|
Cash from Financing Activities
|
-- | 243.45 | 282.07 | 0.16 | 0.16 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-- | 2.31 | 24.76 | -2,636.14 | -88.35 |
|
ROE (%)
|
-- | 3.22 | 33.27 | 170.10 | -90.64 |
|
ROA (%)
|
-- | 2.16 | 21.53 | -39.73 | -50.92 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | 10.20 | 30.81 | -13.81 | -2,293.46 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 0.17 | 0.32 | 0.00 | -1.00 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-- | 686.09 | 3,411.35 | 0.00 | -54.92 |
|
EPS Growth (%)
|
-- | 6.32 | 29.05 | -- | -2.88 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | 57.66 | 36.15 | -- | -0.04 |
|
Price / Book Value
|
-- | 1.67 | 9.95 | -- | 0.02 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 20.18 | 113.70 | -- | 0.06 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 0.38 | 0.57 | -2.13 | 0.03 |
|
Short term debt to equity ratio
|
-- | 0.01 | 0.00 | -0.75 | 0.03 |
|
Current Ratio
|
0.00 | 1.41 | 6.26 | 0.88 | 0.57 |
|
Quick Ratio
|
-- | -- | 6.16 | -- | 8.53 |
|
Interest Coverage
|
-- | 3.22 | -- | -31.30 | -54.10 |
Operating Efficiency Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 16.69 | 16.94 | -- | 0.26 |
|
Asset Turnover
|
-- | 0.21 | 0.70 | 2.88 | 0.02 |
|
Receivable days
|
-- | 55.08 | 53.89 | -- | 33.47 |
|
Inventory Days
|
-- | -15.38 | 30.13 | -- | 332.90 |
|
Payable days
|
-- | 51.57 | 23.32 | 80.44 | 202.97 |
|
Cash Conversion Cycle
|
-- | -14.70 | 60.70 | -- | 163.39 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
